Form 4: Biomea Fusion Insider Reporting Ceases as Director Resigns and Ownership Falls Below 10%
Insider Ownership Change
Bihua Chen and affiliated Cormorant funds will no longer file SEC Form 4 or 5 for Biomea Fusion, Inc. following Ms. Chen's resignation as director and their collective beneficial ownership falling below the 10% threshold.
Summary
- Bihua Chen resigned as a director of Biomea Fusion, Inc. as of July 22, 2025.
- Cormorant Asset Management, LP and its affiliated funds (Cormorant Global Healthcare Master Fund, LP and Cormorant Private Healthcare Fund III, LP), along with Bihua Chen, will cease reporting transactions on Form 4 or Form 5.
- This cessation is due to Ms. Chen's resignation and the reporting persons no longer collectively owning over 10% of Biomea Fusion's outstanding common stock.
- As of the filing date, Cormorant Global Healthcare Master Fund, LP held 1,795,928 shares, Cormorant Private Healthcare Fund III, LP held 1,717,232 shares, and a managed account held 57,712 shares, totaling 3,570,872 shares of common stock indirectly.
- Bihua Chen also holds 202,762 stock options directly, with various exercise prices and expiration dates, granted in her capacity as a former director.
Sentiment
Score: 5
Explanation: Neutral. This is a procedural filing indicating a change in reporting status due to a director's resignation and a reduction in beneficial ownership below the 10% threshold. It does not convey positive or negative sentiment about the company's operations or financial health.
Future Outlook
NA
Management Comments
- Reporting persons no longer intend to report transactions in such securities on Form 4 or Form 5.
Industry Context
This filing is a routine insider transaction report and does not provide broader industry context or trends.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Bihua Chen | NA | 07/22/2025 | Resignation |
Related Party Transactions
- The filing details beneficial ownership by entities managed by Bihua Chen, who was a director. The stock options held by Bihua Chen were granted in her capacity as a director of the Issuer.
Stakeholder Impact
- Shareholders may note the departure of a director and a significant institutional investor (Cormorant) no longer being a 10% owner, which could slightly reduce institutional oversight or signal a shift in investment strategy by Cormorant, though the filing does not specify a sale of shares, only a change in reporting status.
Next Steps
- Reporting persons will no longer file Form 4 or Form 5 for transactions in Biomea Fusion, Inc. securities.
Key Dates
| Date | Description |
|---|---|
| 07/22/2025 | Bihua Chen resigned as a director of Biomea Fusion, Inc. |
| 08/01/2025 | Date of earliest transaction reported and filing date of Form 4. |
| 04/14/2031 | Expiration date for 28,911 stock options with an exercise price of $17. |
| 06/21/2032 | Expiration date for 23,867 stock options with an exercise price of $10.2. |
| 06/13/2033 | Expiration date for 6,989 stock options with an exercise price of $38.9. |
| 06/11/2034 | Expiration date for 51,025 stock options with an exercise price of $4.63. |
| 06/10/2035 | Expiration date for 91,970 stock options with an exercise price of $2.5. |
Recommendation
holdThis Form 4 filing is primarily a procedural update indicating that a former director and affiliated investment funds will cease reporting their holdings due to no longer meeting the 10% beneficial ownership threshold and the director's resignation. It does not contain new financial information, operational updates, or significant transactions that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as there's no new information to alter an existing investment thesis.
Keywords
Biomea Fusion, BMEA, SEC Form 4, Beneficial Ownership, Insider Trading, Director Resignation, Cormorant Asset Management, Stock Options, Healthcare Investment, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.